Macular Degeneration: all 1,490 studies
Page 14 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMDStatus unknownNCT00684853Phase 2
- Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based RetreatmentCompletedNCT00680498Phase 4
- A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF TherapyCompletedNCT00679445Phase 2
- Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or LaserCompletedNCT00668239Not applicable
- Antioxidant Systems and Age-Related Macular DegenerationCompletedNCT00668213
- Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye DropsCompletedNCT00659555Phase 1
- High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular DegenerationCompletedNCT00656903
- Genetics and Markers of Degenerative and Inflammatory Eye DiseasesCompletedNCT00647439
- The Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)Status unknownNCT00640640Not applicable
- Assessment of Macular Edema Using HRT TechniqueStatus unknownNCT00627718Not applicable
- Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGFCompletedNCT00607750Phase 2
- Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or RanibizumabCompletedNCT00605943
- Sensitivity of the Home Macular Perimeter (HMP)CompletedNCT00604071
- Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP)CompletedNCT00603850
- The Natural History of Geographic Atrophy Progression (GAP) StudyTerminatedNCT00599846
- The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) StudyCompletedNCT00599222Phase 3
- Usage of the Home Macular Perimeter (HMP)CompletedNCT00596388
- Sensitivity and Specificity of the Home Macular Perimeter (HMP)CompletedNCT00595998
- Age-Related Eye Disease Study (AREDS) Follow-UpActive, not recruitingNCT00594672
- HMP (Home Macular Perimeter) -Usability TrialCompletedNCT00592826
- Lucentis for Age-related Macular Degeneration Pigment Epithelial DetachmentsCompletedNCT00590694Phase 2/3
- Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMDCompletedNCT00574093Phase 2
- Photodynamic and Pharmacologic Treatment of CNVCompletedNCT00570193Phase 1/2
- Retaane® in Age-Related Macular DegenerationCompletedNCT00569569Phase 2/3
- A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular DegenerationCompletedNCT00569140Phase 1
- Stratus Versus Cirrus OCT in AMDStatus unknownNCT00568191
- Enhancement of Macular Pigment Density by Oral Lutein SupplementationCompletedNCT00563979Not applicable
- Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and RanibizumabStatus unknownNCT00559715Phase 3
- Potential Research Participants for Future Studies of Inherited Eye DiseasesCompletedNCT00559234
- Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)WithdrawnNCT00557791Phase 3
- Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular DegenerationCompletedNCT00556348Phase 4
- A Pilot Study of Functional Optical Coherence Tomography for Ocular ImagingCompletedNCT00556114
- A Study of an Implantable Miniature Telescope in Patients With With End-Stage AMDCompletedNCT00555165Not applicable
- Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque RadiotherapyStatus unknownNCT00540930Phase 4
- Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)WithdrawnNCT00538538Phase 1
- A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMDCompletedNCT00536016Phase 1
- Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian PopulationStatus unknownNCT00533754Not applicable
- Evaluation of Dosing Interval of Higher Doses of RanibizumabCompletedNCT00533520Phase 4
- MAAM Study: Avastin and Macugen Versus Avastin Versus MacugenCompletedNCT00531336Phase 2
- The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD StudyCompletedNCT00531141
- Systemic Avastin Therapy in Age-Related Macular DegenerationCompletedNCT00531024Phase 2/3
- The Effect of Eggs and Egg Products on Macular PigmentCompletedNCT00527553Not applicable
- Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)CompletedNCT00523406Phase 3
- Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMDTerminatedNCT00509548Phase 2
- Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT00504959Phase 4
- Safety and Tolerability of an Intravenous Infusion of ACZ885 in Patients With Wet Age-Related Macular DegenerationCompletedNCT00503022Phase 1
- CAPTAIN:Choroidal Neovascularization Assessment by Pattern ElectroretinographyCompletedNCT00500344Phase 1
- The Role of Macular Pigment in Patients With Age-related Macular DegenerationCompletedNCT00494325
- Effects of Sun Filters on Age-related Macular Degeneration in People With Lens ImplantsWithdrawnNCT00487838
- The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)Status unknownNCT00485394Phase 2
- The Effect of Intravitreal Avastin on the Retina Measured by ElectroretinogramCompletedNCT00478530Not applicable
- Investigation of Macular Pigment Augmentation on Dark AdaptationTerminatedNCT00478439Phase 4
- Study Evaluating Genotypes Using LucentisTerminatedNCT00474695
- Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)CompletedNCT00473928Phase 1
- Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyCompletedNCT00470977Phase 1/2
- EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)CompletedNCT00470678Phase 3
- A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMDCompletedNCT00469352Phase 3
- Scotoma Reduction in AMD Patients Treated With RanibizumabCompletedNCT00467935Phase 1/2
- Copaxone in Age Related Macular DegenerationStatus unknownNCT00466076Phase 2/3
- Oxidative Stress in Patients With Age-Related Macular DegenerationCompletedNCT00465400
- TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular DegenerationTerminatedNCT00464347Phase 2
- A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.CompletedNCT00463320Phase 1
- Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using RheopheresisSuspendedNCT00460967Phase 3
- Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by ItselfWithdrawnNCT00457678Phase 2
- Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMDStatus unknownNCT00455871Not applicable
- A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular DegenerationStatus unknownNCT00454389Phase 3
- Combination Therapy for Neovascular Age Related Macular DegenerationWithdrawnNCT00447031Not applicable
- Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of MelatoninTerminatedNCT00444249Not applicable
- Rheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular DegenerationStatus unknownNCT00443911
- Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVCompletedNCT00429962Phase 3
- Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCompletedNCT00429936Phase 2
- Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMDCompletedNCT00426998Phase 2
- Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)CompletedNCT00417846
- A Phase 1 Safety Study of TG100801 Eye Drops in Healthy VolunteersCompletedNCT00414999Phase 1
- Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)CompletedNCT00413829Phase 2
- Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)CompletedNCT00407719Phase 1
- Efficacy of Retreatments With Intravitreal BevacizumabTerminatedNCT00406744Phase 3
- Selective RPE Laser Treatment (SRT) for Various Macular DiseasesStatus unknownNCT00403884Not applicable
- Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMDTerminatedNCT00403442Phase 1
- Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular DegenerationWithdrawnNCT00403156Phase 1
- Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMDCompletedNCT00401713Not applicable
- Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular DegenerationCompletedNCT00395707Phase 1/2
- Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.CompletedNCT00395551Phase 1
- Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser OphthalmoscopyCompletedNCT00393692
- Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular DegenerationCompletedNCT00390208Phase 2
- The Avastin vs Visudyne for Neovascular AMD StudyWithdrawnNCT00390026Phase 3
- Metabolic Mapping to Measure Retinal MetabolismCompletedNCT00385333Phase 2
- Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMDCompletedNCT00383370Phase 1
- Long-Term Efficacy in AMD of Rheopheresis in North AmericaStatus unknownNCT00380172Not applicable
- Repository for Inherited Eye DiseasesCompletedNCT00378742
- Combination Therapy for Age-Related Macular Degeneration.CompletedNCT00376701Phase 2
- An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMDCompletedNCT00373659Phase 2
- Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMDStatus unknownNCT00370539Phase 3
- Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDStatus unknownNCT00370370Phase 3
- A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00363714Phase 1/2
- Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab.CompletedNCT00359164Phase 2
- PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)CompletedNCT00359008
- PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal NeovascularizationCompletedNCT00358345
- Genetic Study of Age-Related Macular DegenerationCompletedNCT00357578
- A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMDStatus unknownNCT00354445Phase 4